Skip to content

#LSD

19 SepSat
  1. Europe PMC: new psychedelic research papers52

    Review examines psychedelics and suicidality as a double-edged sword

    A review examines the relationship between classic psychedelics such as LSD, psilocybin and DMT and suicidality, proposing a theoretical double-edged sword model. The authors report that several deaths followed non-medical psychedelic use in unsafe contexts, with unclear suicidal intent, and that rare cases of increased suicidal ideation and behaviours in clinical settings showed no significant differences from placebo groups or established causality.

14 SepMon
22 AugSat
12 AugWed
22 JunMon
  1. STAT: psychedelics83

    Definium says LSD therapy DT120 helped major depression in first Phase 3 trial

    Definium Therapeutics said on Monday that its LSD therapy DT120 significantly helped patients with major depression in its first Phase 3 trial. Six weeks after a single dose.

    Why it matters: The topline gives the first Phase 3 readout for an LSD-based depression treatment, so the size of the placebo gap and the waning at 12 weeks are the numbers that will shape the next regulatory step.